SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Dmitry Galkin, Director of the Department for the Development of the Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of Russia.14 June#8455050
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Kirill Kaem, Senior Vice-President for Innovations, Skolkovo Foundation.14 June#8455021
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Sergei Zhdanov, Managing Director, Director of the Health Industry Center, Sberbank.14 June#8455004
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Roman Kozyrev, General Director of RUSTARK.14 June#8455002
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Valentina Kosenko, General Director, Scientific Center for Expertise of Medicinal Products of the Ministry of the Ministry of Health of the Russian Federation.14 June#8454996
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Vasily Ignatyev, General Director, R-Pharm.14 June#8454985
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Pavel Salugin, Vice President of Gazprombank.14 June#8455029
SPIEF-2023. The session on Investing in Cutting-Edge Biotech: Fact or Fiction? Alexander Kolsanov, Rector of the Samara State Medical University.14 June#8454989
